Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2021 07:05 ET | Source: LifeMD, Inc.

LifeMD to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, has been invited to participate at the 33rd Annual ROTH Growth Conference...
March 05, 2021 07:05 ET | Source: LifeMD, Inc.

LifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD) (formerly Conversion Labs), a leading direct-to-patient telehealth company, expects revenue for the first quarter ending...
February 22, 2021 03:30 ET | Source: Conversion Labs, Inc.

Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will begin trading at the opening of the market today...
February 17, 2021 09:25 ET | Source: Conversion Labs, Inc.

Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital...
February 12, 2021 08:30 ET | Source: Conversion Labs, Inc.

Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services

NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the...
February 05, 2021 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective...
January 28, 2021 10:30 ET | Source: Conversion Labs, Inc.

Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has increased its stake in its legacy LegalSimpli Software...
January 19, 2021 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million

NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter and...
January 11, 2021 08:31 ET | Source: Conversion Labs, Inc.

Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and...
January 06, 2021 16:01 ET | Source: Conversion Labs, Inc.

Conversion Labs to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021

NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwright’s BioConnect Conference...